Why does CRISPR randomly fail 15% of the time?

crispr mutations copy
Image credit: Nature

The CRISPR gene editing process is known to fail about 15 percent of the time. These random failures have until now been a mystery to scientists who consistently work with the technique. When the technique is working properly, an enzyme called Cas9 is what actively makes the cuts to a desired position in a DNA strand. After the cut is made either a new desired sequence is added or an unwanted section is simply removed, with the two cut points gluing themselves back together.

The new research revealed that when the CRISPR process fails it is because the Cas9 enzyme effectively sticks to the DNA cut point, blocking the subsequent DNA repair process.

…

The study also found that when RNA polymerases collide with Cas9 they can force the enzyme to dislodge. This means that consistent strand selection can significantly improve the genome editing technique’s efficiency.

“I was shocked that simply choosing one DNA strand over the other had such a powerful effect on genome editing,” says Ryan Clarke, lead author of the study. “Uncovering the mechanism behind this phenomenon helps us better understand how Cas9 interactions with the genome can cause some editing attempts to fail and that, when designing a genome editing experiment, we can use that understanding to our benefit.”

Read full, original post: Researchers discover why the CRISPR gene editing system sometimes fails

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Sep-10-2026-10_36_07-AM
Viewpoint: Even lousy scientific articles can shield authors when they hype dubious health claims and products
ChatGPT-Image-Sep-23-2026-02_36_39-PM
Viewpoint: After firing the entire National Science Board, Trump reshapes funding initiatives. Here’s the good and the bad.
generated-1790707585414
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it
ChatGPT-Image-Sep-21-2026-03_15_09-PM
Viewpoint: Chipotle-inspired lesson: 10,000 sick customers suggest that processed foods can be safer than fresh ones
ChatGPT-Image-Sep-21-2026-11_54_00-AM
Viewpoint: Activist environmental NGOs are turning from public funding to activist billionaires to support their campaigns. It won’t end well.
Screenshot 2026-08-12 at 1.22
Activists vs. Scientists: Could “Butterfly Effect” fears derail gene-drive research targeting the flesh-eating screwworm?
ChatGPT-Image-Sep-22-2026-11_17_31-AM
The exploding controversy over AI’s built-in survival drive
sorghum farmers in kenya FARMERS TREND
Here are all the ways CRISPR gene editing is transforming Africa’s staple crops—and there’s a lot more innovation to come
Screenshot-2026-09-16-at-10.27.33-AM
Viewpoint: SCOTUS poised to address First Amendment tension between mandatory vaccines, children’s health and religious freedom 
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.